Krystal Biotech Statistics
Total Valuation
KRYS has a market cap or net worth of $4.27 billion. The enterprise value is $3.58 billion.
| Market Cap | 4.27B |
| Enterprise Value | 3.58B |
Important Dates
The next estimated earnings date is Monday, February 24, 2025, before market open.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRYS has 28.76 million shares outstanding. The number of shares has increased by 11.06% in one year.
| Current Share Class | 28.76M |
| Shares Outstanding | 28.76M |
| Shares Change (YoY) | +11.06% |
| Shares Change (QoQ) | +0.89% |
| Owned by Insiders (%) | 11.48% |
| Owned by Institutions (%) | 89.58% |
| Float | 22.77M |
Valuation Ratios
The trailing PE ratio is 83.69 and the forward PE ratio is 31.28.
| PE Ratio | 83.69 |
| Forward PE | 31.28 |
| PS Ratio | 17.48 |
| Forward PS | 10.27 |
| PB Ratio | 4.82 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | 73.51 |
| P/OCF Ratio | 67.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 51.79, with an EV/FCF ratio of 61.68.
| EV / Earnings | 68.38 |
| EV / Sales | 14.83 |
| EV / EBITDA | 51.79 |
| EV / EBIT | 55.13 |
| EV / FCF | 61.68 |
Financial Position
The company has a current ratio of 7.97, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.97 |
| Quick Ratio | 7.66 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.13 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.38% and return on invested capital (ROIC) is 4.90%.
| Return on Equity (ROE) | 6.38% |
| Return on Assets (ROA) | 4.58% |
| Return on Capital (ROIC) | 4.90% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | $228,699 |
| Employee Count | 229 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.51 |
Taxes
In the past 12 months, KRYS has paid $5.03 million in taxes.
| Income Tax | 5.03M |
| Effective Tax Rate | 8.76% |
Stock Price Statistics
The stock price has increased by +16.89% in the last 52 weeks. The beta is 0.85, so KRYS's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +16.89% |
| 50-Day Moving Average | 172.45 |
| 200-Day Moving Average | 177.95 |
| Relative Strength Index (RSI) | 37.81 |
| Average Volume (20 Days) | 292,275 |
Short Selling Information
The latest short interest is 3.37 million, so 11.72% of the outstanding shares have been sold short.
| Short Interest | 3.37M |
| Short Previous Month | 3.70M |
| Short % of Shares Out | 11.72% |
| Short % of Float | 14.80% |
| Short Ratio (days to cover) | 11.29 |
Income Statement
In the last 12 months, KRYS had revenue of $241.52 million and earned $52.37 million in profits. Earnings per share was $1.77.
| Revenue | 241.52M |
| Gross Profit | 223.54M |
| Operating Income | 64.95M |
| Pretax Income | 108.38M |
| Net Income | 52.37M |
| EBITDA | 69.15M |
| EBIT | 64.95M |
| Earnings Per Share (EPS) | $1.77 |
Balance Sheet
The company has $588.32 million in cash and $7.48 million in debt, giving a net cash position of $686.74 million or $23.88 per share.
| Cash & Cash Equivalents | 588.32M |
| Total Debt | 7.48M |
| Net Cash | 686.74M |
| Net Cash Per Share | $23.88 |
| Equity (Book Value) | 885.85M |
| Book Value Per Share | 30.80 |
| Working Capital | 623.64M |
Cash Flow
In the last 12 months, operating cash flow was $63.35 million and capital expenditures -$5.28 million, giving a free cash flow of $58.06 million.
| Operating Cash Flow | 63.35M |
| Capital Expenditures | -5.28M |
| Free Cash Flow | 58.06M |
| FCF Per Share | $2.02 |
Margins
Gross margin is 92.55%, with operating and profit margins of 26.89% and 21.68%.
| Gross Margin | 92.55% |
| Operating Margin | 26.89% |
| Pretax Margin | 23.77% |
| Profit Margin | 21.68% |
| EBITDA Margin | 28.63% |
| EBIT Margin | 26.89% |
| FCF Margin | 24.04% |
Dividends & Yields
KRYS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.06% |
| Shareholder Yield | -11.06% |
| Earnings Yield | 1.23% |
| FCF Yield | 1.36% |
Analyst Forecast
The average price target for KRYS is $206.67, which is 39.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $206.67 |
| Price Target Difference | 39.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 72.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRYS has an Altman Z-Score of 27.94 and a Piotroski F-Score of 5.
| Altman Z-Score | 27.94 |
| Piotroski F-Score | 5 |